The surge in innovative drugs and CRO concepts has expanded, with more than a dozen component stocks hitting their daily limit.

Innovative drugs and CRO concepts continued to expand their gains during the trading session. More than ten stocks, including Bid Pharma, Yaokang Bio, Baiposai, Kelaiying, and Baihua Pharmaceuticals, reached their daily limit. Several other stocks, such as Jin'an Protein, Boteng Co., and Haoyuan Pharmaceuticals, rose over 10%.